Ubs Asset Management Americas Inc Instil Bio, Inc. Transaction History

Ubs Asset Management Americas Inc

  • $381 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
$4.21 - $11.15 $33,351 - $88,330
-7,922 Reduced 3.77%
201,968 $933,000
Q1 2022

May 16, 2022
SELL
$8.48 - $18.1 $144,083 - $307,537
-16,991 Reduced 7.49%
209,890 $2.26 Million
Q4 2021

Feb 14, 2022
SELL
$15.37 - $22.5 $72,269 - $105,795
-4,702 Reduced 2.03%
226,881 $3.88 Million
Q3 2021

Nov 15, 2021
SELL
$15.05 - $23.28 $95,958 - $148,433
-6,376 Reduced 2.68%
231,583 $4.14 Million
Q2 2021

Aug 16, 2021
BUY
$15.31 - $24.63 $3.64 Million - $5.86 Million
237,959 New
237,959 $4.6 Million

Others Institutions Holding TIL

# of Institutions
2
Shares Held
1.9M
Call Options Held
0
Put Options Held
0
View Full List

About Instil Bio, Inc.

TIL Quotes by TradingView
  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Ubs Asset Management Americas Inc Portfolio

Follow Ubs Asset Management Americas Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Asset Management Americas Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Asset Management Americas Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email